Clinical Trial Update: Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase I-II study updating on interferon-gamma in HER2-positive breast cancer; the trial has completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Interferon-gamma (interferon gamma)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Breast Cancer, Breast Cancer, Male | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-06-08